Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 mars 2008 09h20 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Acquires Commercialization Rights to Market and Distribute Abiogen's Cancer Drug Abioklad in Greece, Cyprus and Turkey

LAS VEGAS, March 19, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative...
11 mars 2008 09h14 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Signs Exclusive License to Commercialize Two of EUSA's Marketed Oncology Drugs in Greece and Cyprus

Oncology Drugs ERWINASE and KIDROLASE Treat Acute Lymphoblastic Leukemia (ALL) Samaritan Expects Pipeline of 13 Marketed Products to Bring Company Cash Flow Positive by 2009 LAS VEGAS, March...
28 févr. 2008 10h19 HE | Source: Samaritan Pharmaceuticals, Inc.

Managing Director of Samaritan's European Operations Invited to Speak On Press Conference Panel in Recognition of 1st European Rare Disease Day

Samaritan's European Pharmaceutical Marketing Arm Gains Recognition Panel Organized by Greek Ministry of Health and the Greek Alliance of Rare Diseases LAS VEGAS, Feb. 28, 2008 (PRIME NEWSWIRE)...
13 févr. 2008 09h29 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Therapeutics Names Entrepreneurial MD President

MONTREAL, Feb. 13, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals (OTCBB:SPHC) and Samaritan Therapeutics, a Montreal research and development biotech company, minority owned by Samaritan...
05 févr. 2008 09h04 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Sales Revenue Growing

LAS VEGAS, Feb. 5, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, is pleased to...
24 janv. 2008 10h33 HE | Source: Samaritan Pharmaceuticals, Inc.

Huntington Disease Foundation to Assess Six of Samaritan's Drugs for Potential to Delay or Slow Progression of the Disease

CHDI Foundation's Initial Due Diligence Finds Neuroprotective Properties of Samaritan's Alzheimer's Drug's Intriguing LAS VEGAS, Jan. 24, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc....
22 janv. 2008 09h48 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales

LAS VEGAS, Jan. 22, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
07 janv. 2008 09h56 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board

LAS VEGAS, Jan. 7, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical company focused on developing innovative therapeutics in the areas of CNS, cancer,...
27 déc. 2007 10h15 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Anticipates Continued Growth in 2008

Management Proves Their Ability to Persist on Successful Path in 2007, * Advanced Three Promising Breakthrough Drugs On Human Clinical Trial Path * Successfully In-Licensed 11 Specialty...
19 déc. 2007 10h43 HE | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharmaceuticals Receives Pricing Approval in Greece for Hunters Syndrome Drug ELAPRASE

LAS VEGAS, Dec. 19, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...

Page suivante